Genitourinary manifestations of the acquired immunodeficiency syndrome

Kwan, David; Lowe, Franklin C.

doi:10.1016/s0090-4295(95)96214-x

Cited by 32 publications

(20 citation statements)

References 94 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some authors have suggested that PCa may be more aggressive in patients with HIV; although this study has a limited number of HIV-positive patients with high CD4 counts and low viral loads, it does not support these assertions. 25 The findings of Huang et al 21 were similar to ours (although with a smaller series, different surgical approach and longer follow-up): negative surgical margins in five patients with known HIV who underwent open radical retropubic prostatectomy. No patients had biochemical recurrence after a median follow-up of 26 months.…”

Section: Ralp In Men With Hiv Jl Silberstein Et Alsupporting

confidence: 76%

Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus

Silberstein

Parsons

Palazzi-Churas

et al. 2010

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate (v 2 , Mann-Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (o50); mean CD4 count was 634 cells per mm 3 . HIV-positive men were younger (54 versus 62 years, P ¼ 0.010) and less likely to be white (P ¼ 0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P ¼ 0.031) and ileus (P ¼ 0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P ¼ 0.002). After a median of 2.6 (range 0.03-19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.

show abstract

Section: Ralp In Men With Hiv Jl Silberstein Et Alsupporting

confidence: 76%

Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus

Silberstein

Parsons

Palazzi-Churas

et al. 2010

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

show abstract

“…Germ cell testicular tumours are the third most common AIDS-related malignancy; it is estimated to be 50 times more common in HIV-positive men, with two new cases per 1000 HIV-infected persons, compared with 3.5 per 100 000 of the male population [18,74,75]. These tumours tend to be more aggressive with a greater incidence of bilateral presentation.…”

Section: Malignancymentioning

confidence: 99%

The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome

2001

View full text Add to dashboard Cite

“…and Salmonella spp. 14,15,17,20,22 Pathogens in the urine of HIV-infected patients have shown high antimicrobial resistance. 23 Atypical pathogens that have the capacity to cause a UTI in patients with HIV include fungi (Candida albicans, Aspergillus fumigatus, Blastomyces spp.,Cryptococcus neoformans, Cryptosporidium spp.…”

Section: Urinary Tract Infectionmentioning

confidence: 99%